p.novotny
TL2 Regular · Prague, CZ
Lifter. Interested in preserving what I spent a decade building while losing fat.
Joined 3 June 2025 · last posted 4d
102 posts, newest first. Showing up to 150.
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #106 · Access › International · 24 Jul 2026 · 4 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
-
Restarting after a long gap: what the labelling implies Replied, post #37 · Practice › Dosing & titration · 21 Jul 2026 · 3 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #24 · Sourcing › Regulatory · 15 Jul 2026 · 0 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
Follow-up: Signs of dehydration worth acting on Replied, post #25 · Safety › Adverse events · 15 Jul 2026 · 0 likes Serious and unexpected events are the ones to document and report. Serious means hospitalization-level serious. Unexpected means not in the drug's known profile. Both…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #60 · Practice › Dosing & titration · 13 Jul 2026 · 8 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #57 · Compounds › Retatrutide · 12 Jul 2026 · 2 likes I read post #55 twice before replying, because I had assumed the opposite. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist.…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #52 · Analytics › Impurities & related substances · 6 Jul 2026 · 13 likes I read post #50 twice before replying, because I had assumed the opposite. Truncation products: fragments from incomplete synthesis or from degradation. They elute…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #111 · Evidence › Journal club · 5 Jul 2026 · 20 likes Coming back to post #109, because the follow-up matters more than the original answer. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the…
-
Submitting a sample: the process end to end Replied, post #58 · Sourcing › Independent verification · 4 Jul 2026 · 29 likes This follows post #55 rather than contradicting it. Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a…
-
NHS criteria and how they are applied in practice Replied, post #8 · Regional › UK & Ireland · 21 Jun 2026 · 2 likes post #7 is right about the mechanism and I think understates the practical bit. Compounding pharmacies: UK allows compounding under specific conditions when a licensed…
-
Racemisation and why it is invisible to a mass measurement Replied, post #123 · Analytics › Impurities & related substances · 15 Jun 2026 · 0 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…
-
Fixed versus detachable needles: the trade-offs — does this still hold? Replied, post #7 · Devices › Syringes & needles · 13 Jun 2026 · 0 likes I read post #5 twice before replying, because I had assumed the opposite. Reading units correctly: look at the marking from the side, not from above or below. The…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #105 · Practice › Storage & stability · 9 Jun 2026 · 22 likes Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #123 · Compounds › Tirzepatide · 3 Jun 2026 · 1 like post #122 is right about the mechanism and I think understates the practical bit. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long.…
-
Electrolyte supplements: which ones do anything Replied, post #22 · Nutrition & Training › Hydration & electrolytes · 3 Jun 2026 · 0 likes Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration or electrolyte depletion. Increasing fluids, salt, and potassium usually resolves…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #52 · Practice › Storage & stability · 1 Jun 2026 · 10 likes Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure is worth avoiding. The concentration matters…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #19 · Compounds › Oral incretins · 29 May 2026 · 22 likes post #18 answers the question as asked. The question underneath it is different. Trial adherence in an oral trial with strict administration requirements is genuinely…
-
Research-use-only status: what it means legally and practically Replied, post #42 · Compounds › Other compounds · 14 May 2026 · 2 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
Sample handling between despatch and injection Replied, post #55 · Analytics › Method validation · 20 Apr 2026 · 7 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #4 · marked as the solution · Analytics › Home & field testing · 18 Apr 2026 · 7 likes What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
-
The "under review" status pill and when a moderator applies it Replied, post #73 · Evidence › Preprints · 14 Apr 2026 · 2 likes Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #27 · Evidence › Journal club · 11 Apr 2026 · 5 likes Worth separating two things that post #23 runs together. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a…
-
A site rotation scheme that is easy enough to actually follow Replied, post #38 · Practice › Administration · 11 Apr 2026 · 12 likes post #37 answers the question as asked. The question underneath it is different. Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #75 · Practice › Interactions · 5 Apr 2026 · 26 likes On post #71 — agreed on the reasoning, with one qualification. Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #8 · Wellbeing › Sleep · 3 Apr 2026 · 16 likes Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves (apnoea-hypopnoea index goes up as soft tissue inflames before weight is lost).…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #115 · Clinical › Bloodwork · 30 Mar 2026 · 0 likes HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
-
Personal import allowances, compared — a second dataset Replied, post #94 · Access › International · 29 Mar 2026 · 0 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #76 · Start Here › How to Ask · 21 Mar 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #53 · Research Methods › N-of-1 designs · 9 Mar 2026 · 12 likes Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people…
-
Reading an interaction checker output critically Replied, post #131 · Practice › Interactions · 26 Feb 2026 · 2 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #129 · Compounds › Semaglutide · 26 Feb 2026 · 25 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Whether protein timing matters at a large deficit Replied, post #27 · Nutrition & Training › Protein & intake · 20 Feb 2026 · 22 likes Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as satiating as solid food. Using both together can help.
-
Revisiting: Maintainer handover: how it works Replied, post #7 · Meta › Wiki maintenance · 20 Feb 2026 · 5 likes Coming back to post #5, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #8 · Practice › Dosing & titration · 14 Feb 2026 · 27 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #39 · Clinical › Special populations · 11 Feb 2026 · 0 likes Worth separating two things that post #35 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #15 · Outcomes › Progress reports · 7 Feb 2026 · 29 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
-
Preprint servers and what screening they do Replied, post #27 · Evidence › Preprints · 17 Jan 2026 · 2 likes Worth separating two things that post #23 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #36 · Practice › Side effects · 16 Jan 2026 · 0 likes Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #20 · Practice › Side effects · 3 Jan 2026 · 16 likes On post #16 — agreed on the reasoning, with one qualification. Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #15 · Research Methods › N-of-1 designs · 28 Dec 2025 · 10 likes I read post #13 twice before replying, because I had assumed the opposite. Confounding in personal experiments: other things change when you start a medication (season,…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #57 · Practice › Side effects · 28 Dec 2025 · 11 likes Worth separating two things that post #53 runs together. Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated…
-
Why "add 2 mL" is not an instruction Replied, post #22 · Practice › Reconstitution · 27 Dec 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Reconciling a label claim with a content assay Replied, post #5 · Analytics › COA interpretation · 26 Dec 2025 · 1 like Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
Publishing an inconvenient result: a case study — the long version Replied, post #48 · Sourcing › Independent verification · 24 Nov 2025 · 24 likes post #47 answers the question as asked. The question underneath it is different. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #18 · Sourcing › Independent verification · 20 Nov 2025 · 0 likes I read post #16 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #90 · Start Here › How to Ask · 13 Nov 2025 · 33 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
What a purity-only report leaves out Replied, post #81 · Sourcing › Independent verification · 10 Nov 2025 · 0 likes post #80 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
How to read a forest plot, properly, from scratch Replied, post #51 · Evidence › Trials · 6 Nov 2025 · 12 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #11 · Pharmacology › Pharmacokinetics · 30 Oct 2025 · 5 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #66 · Safety › Adverse events · 28 Oct 2025 · 11 likes Severe gastrointestinal events: persistent vomiting, abdominal pain out of proportion, or signs of bowel obstruction warrant urgent evaluation. Mild nausea and…
-
What a purity-only report leaves out Replied, post #62 · Sourcing › Independent verification · 27 Oct 2025 · 4 likes I read post #60 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #42 · Compounds › Oral incretins · 17 Oct 2025 · 28 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
High-resolution MS on aggregates and what it can see Replied, post #90 · Analytics › Mass spectrometry · 11 Oct 2025 · 28 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
An orphaned page with no inbound links — the long version Replied, post #11 · Meta › Wiki maintenance · 10 Oct 2025 · 16 likes I read post #9 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #99 · Analytics › HPLC & UHPLC · 8 Oct 2025 · 0 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
-
Hypertension improvement and when medication needs revisiting Replied, post #65 · Clinical › Comorbidities · 17 Sep 2025 · 1 like Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific…
-
Payment method and the leverage it gives you, ranked Replied, post #18 · Sourcing › Payments · 16 Sep 2025 · 6 likes post #17 answers the question as asked. The question underneath it is different. Recurring billing: if a supplier sets up recurring billing by default, understanding…
-
Documentation that appears only after payment Replied, post #22 · Sourcing › Red flags · 10 Sep 2025 · 19 likes post #21 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #23 · Analytics › Method validation · 30 Aug 2025 · 19 likes post #22 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #40 · Analytics › HPLC & UHPLC · 30 Aug 2025 · 0 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #17 · Practice › Storage & stability · 29 Aug 2025 · 22 likes Picking up post #14: that is the part I would want checked first. Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the…
-
Thyroid function tests during substantial weight change Replied, post #44 · Clinical › Bloodwork · 28 Aug 2025 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #60 · Compounds › Oral incretins · 7 Jul 2025 · 26 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
-
Coming back to: Official shortage notices and what they authorise Replied, post #45 · Access › Shortages · 1 Jul 2025 · 9 likes I read post #43 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Repeatability versus intermediate precision Replied, post #41 · Analytics › Method validation · 22 Jun 2025 · 1 like Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #139 · Practice › Reconstitution · 19 Jun 2025 · 0 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #139 · Evidence › Journal club · 17 Jun 2025 · 7 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #30 · Compounds › Repair & healing peptides · 3 Jun 2025 · 12 likes post #29 answers the question as asked. The question underneath it is different. Oral versus injected administration claims for BPC-157: the preclinical work studied…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #94 · Data & Tools › Calculators · 27 May 2025 · 0 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
-
Second pass at: Designing a personal experiment that could change your mind Replied, post #24 · Research Methods › N-of-1 designs · 19 May 2025 · 30 likes Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #77 · Data & Tools › Calculators · 19 May 2025 · 0 likes Coming back to post #75, because the follow-up matters more than the original answer. Precision and significant figures: the calculators do not round to match your…
-
Coverage for the indication versus for the drug Replied, post #61 · Access › Insurance & coverage · 11 May 2025 · 5 likes Coming back to post #59, because the follow-up matters more than the original answer. Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #23 · Outcomes › Body composition · 10 May 2025 · 25 likes This follows post #20 rather than contradicting it. Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during…
-
Titles that describe the question, not the situation Replied, post #8 · Start Here › How to Ask · 9 May 2025 · 1 like Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #43 · Sourcing › Independent verification · 3 May 2025 · 1 like When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Publishing an inconvenient result: a case study Replied, post #14 · Sourcing › Independent verification · 30 Apr 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Why plausible mechanism is not evidence of effect — one year on Replied, post #2 · Compounds › Repair & healing peptides · 27 Apr 2025 · 6 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Metformin co-administration and additive GI effects Replied, post #12 · Practice › Interactions · 24 Apr 2025 · 5 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #44 · Evidence › Journal club · 19 Apr 2025 · 21 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
Follow-up: Documentation that appears only after payment Replied, post #5 · Sourcing › Red flags · 17 Apr 2025 · 1 like post #4 answers the question as asked. The question underneath it is different. Pricing patterns: unusually low prices for what are otherwise consistent with market…
-
Fibre intake when total intake falls, and the constipation link Replied, post #48 · Nutrition & Training › Protein & intake · 2 Apr 2025 · 9 likes This follows post #45 rather than contradicting it. Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as satiating as…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #127 · Compounds › Semaglutide · 13 Mar 2025 · 6 likes Worth separating two things that post #123 runs together. Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #34 · Compounds › Tirzepatide · 7 Mar 2025 · 8 likes Coming back to post #32, because the follow-up matters more than the original answer. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #47 · Sourcing › Red flags · 2 Feb 2025 · 19 likes This follows post #44 rather than contradicting it. Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is…
-
What we do not know about retatrutide, listed explicitly Replied, post #76 · Compounds › Retatrutide · 30 Jan 2025 · 0 likes Worth separating two things that post #72 runs together. Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose.…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #51 · Compounds › Oral incretins · 14 Jan 2025 · 0 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
-
Follow-up: Individual participant data versus aggregate data Replied, post #16 · Evidence › Meta-analyses · 8 Jan 2025 · 28 likes Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether the pooled estimate changes. Robust results…
-
Oxidation pathways for methionine and tryptophan Replied, post #6 · Analytics › Impurities & related substances · 25 Dec 2024 · 19 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #82 · Compounds › Semaglutide · 24 Dec 2024 · 4 likes On post #78 — agreed on the reasoning, with one qualification. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #79 · Devices › Syringes & needles · 9 Dec 2024 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Follow-up: Recovery when intake is low: what to cut first Replied, post #40 · Nutrition & Training › Resistance training · 23 Nov 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #46 · Clinical › Special populations · 23 Nov 2024 · 4 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #38 · Evidence › Journal club · 21 Nov 2024 · 2 likes Worth separating two things that post #34 runs together. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not…
-
Isotope patterns and why the monoisotopic peak is not the tallest Replied, post #3 · Analytics › Mass spectrometry · 18 Nov 2024 · 0 likes Worth separating two things that the opening post runs together. Resolution: "high resolution" commonly means
-
Why "any advice?" is the least effective ending for a post Replied, post #41 · Start Here › How to Ask · 16 Nov 2024 · 0 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
-
Revisiting: Moderation log format change Replied, post #26 · Meta › Announcements · 13 Nov 2024 · 7 likes post #25 is right about the mechanism and I think understates the practical bit. Scheduled maintenance: if the site is going offline for maintenance, advance notice…
-
Why "any advice?" is the least effective ending for a post Replied, post #7 · Start Here › How to Ask · 3 Nov 2024 · 0 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
Requesting a page: what makes a good request — what changed since Replied, post #129 · Documentation › Wiki requests · 13 Oct 2024 · 0 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #29 · Wellbeing › Mental health · 13 Oct 2024 · 0 likes Coming back to post #27, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #10 · Compounds › Cagrilintide & amylin analogues · 12 Oct 2024 · 3 likes For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical evidence and what it does and does not establish. It does not…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #17 · Evidence › Journal club · 14 Aug 2024 · 0 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Journal club: FLOW and the renal composite, component by component Replied, post #69 · Evidence › Journal club · 15 Jul 2024 · 19 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…